Next Stop: Euphoria
This isn't about calling a market top -- there is no formula to tell us how long each of these phases may persist. This is more about acknowledging the psychology associated with each, and becoming aware of the real risks to which our portfolios are subject. It's also about being willing to stick our necks out, and potentially look foolish for a period of time.
Could U.S. markets go higher from here? Sure. But how much gas is really left in the tank?
You may be watching headlines -- seemingly each day the past two weeks -- broadcasting all-time highs for the Dow and S&P 500. It's possible your portfolio is at its all-time high. Shares of many household names are at their all-time highs: Berkshire Hathaway (BRK.A), Boeing (BA), Clorox (CLX), Johnson & Johnson (JNJ), Macy's (M) and Wells Fargo (WFC) are all at their all-time highs. There may not be much further for such names to run.But the "excitement" and "thrill" phases have not treated all stocks equally. Some still look cheap, in fact. Whereas those names listed above sit at or near all-time highs, comparable names are nowhere near theirs.
Compare Berkshire and Boeing to General Electric (GE - Get Report), JNJ to Pfizer (PFE), Macy's to Target (TGT), Wells Fargo to Bank of America (BAC). General Electric, Pfizer, Target and Bank of America have severely lagged their peers. This fact on its own does not make them good values, but I doubt their annual shareholder meetings feel particularly euphoric.
"We bring good things to life (except our stock price)" GE is a stock that -- due to the virtual insolvency of its GE Capital division during the crisis -- has traded like a bank for the past five years. A bank on the brink. Not taking into account its dividend, shares of GE are down 30% since 2007. Go back a little further and you'll see GE shares are down 15% over the past 10 years, and 20% over the past 15 years. The stock has been out-performed by your checking account since Jack Welch left in 2001.
You can run but you can't hide.... We aren't going to be able to avoid the Euphoria stage -- it's inevitable. But is it prudent to take no action in advance? We have trimmed if not eliminated exposure to many positions in client portfolios this year -- just about every position that is at its all-time high. In some cases our portfolios look dramatically different today than they did six months ago. For example, our allocation to long-dated Treasury Bonds (TLT) is now at its highest point in years (after having been zero in January). We can't avoid market cycles, but it's our job to prepare for them. At the time of publication the author was long BAC,TLT and VOO. Follow @ArgyleCapital This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff. >>5 Toxic Stocks You Should Sell This Summer